NYSE Content Advisory: Pre-Market update + Block Exceeds $200 Billion in Credit Provided to Its Users
NEW YORK, Jan. 27, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. NYSE Content...
Combatting the Energy Crisis: Eworld Showcases Low-Energy Glass Processing Machinery and Sustainable Solutions at Major Global Expos
International trade shows highlight Eworld's energy-efficient glass processing technologies for architectural and industrial applications JINAN, China, Jan. 27, 2026 /PRNewswire/ -- High energy costs and tightening environmental regulations are no...
Tineco Elevates Modern Living With a Smarter, More Balanced Floor Care Portfolio
SEATTLE, Jan. 27, 2026 /PRNewswire/ -- As modern homes continue to evolve, consumers are increasingly seeking appliances that combine performance, thoughtful design, and long-term value. Tineco, a leader in intelligent floor care solutions, brings...
Beetles Gel Polish Celebrates 5-Star Women's Basketball Recruit Jerzy Robinson's College Commitment
Top ranked women's basketball recruit Jerzy Robinson marks a defining life chapter through self-expression with Beetles Gel Polish. NEW YORK, Jan. 27, 2026 /PRNewswire/ -- As young athletes navigate high-pressure moments both on and off the court,...
Home Control Signs Memorandum of Understanding with NTU Singapore to Explore AIoT Home Healthcare Ecosystem
HONG KONG, Jan. 27, 2026 /PRNewswire/ -- Home Control International Limited ("Home Control" or the "Company", together with its subsidiaries, the "Group"; Stock Code: 1747.HK) is pleased to announce that it has entered into a Strategic Memorandum of...
AGCO Foundation Partners with the University of Sydney to Boost Resilience in Rural Communities
The AU$150,000 partnership will create a dedicated agriculture program for the university. DULUTH, Ga., Jan. 28, 2026 /PRNewswire/ -- AGCO Foundation, a private foundation working to transform lives in farming communities, announced a new...
Skyhawk Therapeutics Announces Nine Month Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington's Disease
Nine-month findings show mean improvement in Composite Unified Huntington's Disease Rating Scale from baseline of +0.64 points, compared to natural history expected worsening of cUHDRS in symptomatic patients of -0.73 points over nine months, based...
Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer
SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase 1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV),...